tiprankstipranks
Ocular Therapeutix (OCUL)
NASDAQ:OCUL

Compare Ocular Therapeutix (OCUL) vs. Competitors

Compare
1,586 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Ocular Therapeutix
$8.07
$1.76B
5.22%
10 Buy
0 Hold
0 Sell
Strong Buy
Beam Therapeutics
$23.62
$2.41B
-34.27
7.80%
12 Buy
2 Hold
0 Sell
Strong Buy
Tarsus Pharmaceuticals
$67.20
$2.86B
-51.51
31.74%
8 Buy
1 Hold
0 Sell
Strong Buy
ARS Pharmaceuticals
$8.56
$849.98M
-6.70
-32.06%
3 Buy
0 Hold
0 Sell
Strong Buy
Belite Bio, Inc. ADR
$149.18
$5.87B
-69.12
128.77%
7 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
OCUL
Ocular Therapeutix
8.07
0.32
4.13%
ETNB
BEAM
Beam Therapeutics
23.62
1.43
6.44%
TARS
Tarsus Pharmaceuticals
67.20
16.55
32.68%
SPRY
ARS Pharmaceuticals
8.56
-4.07
-32.22%
BLTE
Belite Bio, Inc. ADR
149.18
82.33
123.16%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts